S799 Health-Related Quality of Life with Guselkumab Induction and Maintenance Therapy as Measured by PROMIS-29: Results Through Week 48 of Phase 2 GALAXI 1 Study

التفاصيل البيبلوغرافية
العنوان: S799 Health-Related Quality of Life with Guselkumab Induction and Maintenance Therapy as Measured by PROMIS-29: Results Through Week 48 of Phase 2 GALAXI 1 Study
المؤلفون: David T. Rubin, Bruce E. Sands, Remo Panaccione, Chenglong Han, Kathleen Weisel, Mary Ellen Frustaci, Zijiang Yang, Aparna Sahoo, Anita Afzali, Jane Andrews, Silvio Danese, Tadakazu Hisamatsu, Brian G. Feagan, Julian Panés, Walter Reinisch, William J. Sandborn, Geert D’Haens
المصدر: American Journal of Gastroenterology. 117:e569-e570
بيانات النشر: Ovid Technologies (Wolters Kluwer Health), 2022.
سنة النشر: 2022
مصطلحات موضوعية: Hepatology, Gastroenterology
تدمد: 1572-0241
0002-9270
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::af5585316e2b47218edf9aa63834f98e
https://doi.org/10.14309/01.ajg.0000859836.33457.73
رقم الأكسشن: edsair.doi...........af5585316e2b47218edf9aa63834f98e
قاعدة البيانات: OpenAIRE